 | • レポートコード：D0GIR-02305 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、結核検査・診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。結核検査・診断の種類別市場規模（塗抹顕微鏡検査、核酸検査、ラジオグラフィー、ツベルクリン皮膚検査（TST）、インターフェロンガンマリリースアッセイ（IGRA）、その他）、用途別市場規模（病院・診療所、診断検査室、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Roche、Oxford Immunotec、Abbott、Thermo Fischer Scientific、Sanofi、Becton Dickinson、Par Sterile、Qiagen、Hologic、BioMerieux、Hain Lifescience、Bio-Rad Laboratories、Epistem、Siemens Healthineer、Akonni Biosystems、Creative Diagnostics、Cepheid ・地域別グローバル市場分析 2015年-2020年 ・結核検査・診断の北米市場（アメリカ、カナダ、メキシコ） ・結核検査・診断のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・結核検査・診断のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・結核検査・診断の南米市場（ブラジル、アルゼンチン） ・結核検査・診断の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：塗抹顕微鏡検査、核酸検査、ラジオグラフィー、ツベルクリン皮膚検査（TST）、インターフェロンガンマリリースアッセイ（IGRA）、その他 ・用途別分析：病院・診療所、診断検査室、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Tuberculosis Testing and Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Tuberculosis Testing and Diagnostics sales will be xx in 2020 from Tuberculosis Testing and Diagnostics million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Tuberculosis Testing and Diagnostics market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Tuberculosis Testing and Diagnostics industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Tuberculosis Testing and Diagnostics and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Tuberculosis Testing and Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Tuberculosis Testing and Diagnostics market has been segmented into:
Smear Microscopy
Nucleic Acid Testing
Radiography
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Others
By Application, Tuberculosis Testing and Diagnostics has been segmented into:
Hospitals and Clinics
Diagnostic Laboratories
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Tuberculosis Testing and Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level Tuberculosis Testing and Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Tuberculosis Testing and Diagnostics market.
The report offers in-depth assessment of the growth and other aspects of the Tuberculosis Testing and Diagnostics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Tuberculosis Testing and Diagnostics Market Share Analysis
Tuberculosis Testing and Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Tuberculosis Testing and Diagnostics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Tuberculosis Testing and Diagnostics sales, revenue and market share for each player covered in this report.
The major players covered in Tuberculosis Testing and Diagnostics are:
Roche
Oxford Immunotec
Abbott
Thermo Fischer Scientific
Sanofi
Becton Dickinson
Par Sterile
Qiagen
Hologic
BioMerieux
Hain Lifescience
Bio-Rad Laboratories
Epistem
Siemens Healthineer
Akonni Biosystems
Creative Diagnostics
Cepheid
Among other players domestic and global, Tuberculosis Testing and Diagnostics market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Tuberculosis Testing and Diagnostics Market Overview
1.1 Product Overview and Scope of Tuberculosis Testing and Diagnostics
1.2 Classification of Tuberculosis Testing and Diagnostics by Type
1.2.1 Global Tuberculosis Testing and Diagnostics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Tuberculosis Testing and Diagnostics Revenue Market Share by Type in 2019
1.2.3 Smear Microscopy
1.2.4 Nucleic Acid Testing
1.2.5 Radiography
1.2.6 Tuberculin Skin Test (TST)
1.2.7 Interferon Gamma Released Assay (IGRA)
1.2.8 Others
1.3 Global Tuberculosis Testing and Diagnostics Market by Application
1.3.1 Overview: Global Tuberculosis Testing and Diagnostics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Global Tuberculosis Testing and Diagnostics Market by Regions
1.4.1 Global Tuberculosis Testing and Diagnostics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Tuberculosis Testing and Diagnostics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Tuberculosis Testing and Diagnostics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Tuberculosis Testing and Diagnostics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Tuberculosis Testing and Diagnostics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Tuberculosis Testing and Diagnostics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Tuberculosis Testing and Diagnostics Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Tuberculosis Testing and Diagnostics Industry Impact
1.5.1 COVID-19 Potential Implications for the Tuberculosis Testing and Diagnostics
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Tuberculosis Testing and Diagnostics
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Oxford Immunotec
2.2.1 Oxford Immunotec Details
2.2.2 Oxford Immunotec Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Oxford Immunotec SWOT Analysis
2.2.4 Oxford Immunotec Product and Services
2.2.5 Oxford Immunotec Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Abbott SWOT Analysis
2.3.4 Abbott Product and Services
2.3.5 Abbott Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Thermo Fischer Scientific
2.4.1 Thermo Fischer Scientific Details
2.4.2 Thermo Fischer Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Thermo Fischer Scientific SWOT Analysis
2.4.4 Thermo Fischer Scientific Product and Services
2.4.5 Thermo Fischer Scientific Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanofi SWOT Analysis
2.5.4 Sanofi Product and Services
2.5.5 Sanofi Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Becton Dickinson
2.6.1 Becton Dickinson Details
2.6.2 Becton Dickinson Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Becton Dickinson SWOT Analysis
2.6.4 Becton Dickinson Product and Services
2.6.5 Becton Dickinson Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Par Sterile
2.7.1 Par Sterile Details
2.7.2 Par Sterile Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Par Sterile SWOT Analysis
2.7.4 Par Sterile Product and Services
2.7.5 Par Sterile Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Qiagen
2.8.1 Qiagen Details
2.8.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Qiagen SWOT Analysis
2.8.4 Qiagen Product and Services
2.8.5 Qiagen Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Hologic
2.9.1 Hologic Details
2.9.2 Hologic Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Hologic SWOT Analysis
2.9.4 Hologic Product and Services
2.9.5 Hologic Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.10 BioMerieux
2.10.1 BioMerieux Details
2.10.2 BioMerieux Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 BioMerieux SWOT Analysis
2.10.4 BioMerieux Product and Services
2.10.5 BioMerieux Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Hain Lifescience
2.11.1 Hain Lifescience Details
2.11.2 Hain Lifescience Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Hain Lifescience SWOT Analysis
2.11.4 Hain Lifescience Product and Services
2.11.5 Hain Lifescience Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.12 Bio-Rad Laboratories
2.12.1 Bio-Rad Laboratories Details
2.12.2 Bio-Rad Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Bio-Rad Laboratories SWOT Analysis
2.12.4 Bio-Rad Laboratories Product and Services
2.12.5 Bio-Rad Laboratories Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.13 Epistem
2.13.1 Epistem Details
2.13.2 Epistem Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Epistem SWOT Analysis
2.13.4 Epistem Product and Services
2.13.5 Epistem Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.14 Siemens Healthineer
2.14.1 Siemens Healthineer Details
2.14.2 Siemens Healthineer Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Siemens Healthineer SWOT Analysis
2.14.4 Siemens Healthineer Product and Services
2.14.5 Siemens Healthineer Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.15 Akonni Biosystems
2.15.1 Akonni Biosystems Details
2.15.2 Akonni Biosystems Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Akonni Biosystems SWOT Analysis
2.15.4 Akonni Biosystems Product and Services
2.15.5 Akonni Biosystems Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.16 Creative Diagnostics
2.16.1 Creative Diagnostics Details
2.16.2 Creative Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Creative Diagnostics SWOT Analysis
2.16.4 Creative Diagnostics Product and Services
2.16.5 Creative Diagnostics Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.17 Cepheid
2.17.1 Cepheid Details
2.17.2 Cepheid Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Cepheid SWOT Analysis
2.17.4 Cepheid Product and Services
2.17.5 Cepheid Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Tuberculosis Testing and Diagnostics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Tuberculosis Testing and Diagnostics Players Market Share
3.2.2 Top 10 Tuberculosis Testing and Diagnostics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Tuberculosis Testing and Diagnostics Revenue and Market Share by Regions
4.2 North America Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
4.3 Europe Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
4.5 South America Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
5 North America Tuberculosis Testing and Diagnostics Revenue by Countries
5.1 North America Tuberculosis Testing and Diagnostics Revenue by Countries (2015-2020)
5.2 USA Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
5.3 Canada Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
5.4 Mexico Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
6 Europe Tuberculosis Testing and Diagnostics Revenue by Countries
6.1 Europe Tuberculosis Testing and Diagnostics Revenue by Countries (2015-2020)
6.2 Germany Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
6.3 UK Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
6.4 France Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
6.5 Russia Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
6.6 Italy Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Tuberculosis Testing and Diagnostics Revenue by Countries
7.1 Asia-Pacific Tuberculosis Testing and Diagnostics Revenue by Countries (2015-2020)
7.2 China Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
7.3 Japan Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
7.4 Korea Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
7.5 India Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
8 South America Tuberculosis Testing and Diagnostics Revenue by Countries
8.1 South America Tuberculosis Testing and Diagnostics Revenue by Countries (2015-2020)
8.2 Brazil Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
8.3 Argentina Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Tuberculosis Testing and Diagnostics by Countries
9.1 Middle East & Africa Tuberculosis Testing and Diagnostics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
9.3 UAE Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
9.4 Egypt Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
9.5 South Africa Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Tuberculosis Testing and Diagnostics Revenue and Market Share by Type (2015-2020)
10.2 Global Tuberculosis Testing and Diagnostics Market Forecast by Type (2019-2024)
10.3 Smear Microscopy Revenue Growth Rate (2015-2025)
10.4 Nucleic Acid Testing Revenue Growth Rate (2015-2025)
10.5 Radiography Revenue Growth Rate (2015-2025)
10.6 Tuberculin Skin Test (TST) Revenue Growth Rate (2015-2025)
10.7 Interferon Gamma Released Assay (IGRA) Revenue Growth Rate (2015-2025)
10.8 Others Revenue Growth Rate (2015-2025)
11 Global Tuberculosis Testing and Diagnostics Market Segment by Application
11.1 Global Tuberculosis Testing and Diagnostics Revenue Market Share by Application (2015-2020)
11.2 Tuberculosis Testing and Diagnostics Market Forecast by Application (2019-2024)
11.3 Hospitals and Clinics Revenue Growth (2015-2020)
11.4 Diagnostic Laboratories Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Tuberculosis Testing and Diagnostics Market Size Forecast (2021-2025)
12.1 Global Tuberculosis Testing and Diagnostics Market Size Forecast (2021-2025)
12.2 Global Tuberculosis Testing and Diagnostics Market Forecast by Regions (2021-2025)
12.3 North America Tuberculosis Testing and Diagnostics Revenue Market Forecast (2021-2025)
12.4 Europe Tuberculosis Testing and Diagnostics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Tuberculosis Testing and Diagnostics Revenue Market Forecast (2021-2025)
12.6 South America Tuberculosis Testing and Diagnostics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Tuberculosis Testing and Diagnostics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Tuberculosis Testing and Diagnostics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Tuberculosis Testing and Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Tuberculosis Testing and Diagnostics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Tuberculosis Testing and Diagnostics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Tuberculosis Testing and Diagnostics Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Roche Corporate Information, Location and Competitors
Table 7. Roche Tuberculosis Testing and Diagnostics Major Business
Table 8. Roche Tuberculosis Testing and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 9. Roche SWOT Analysis
Table 10. Roche Tuberculosis Testing and Diagnostics Product and Solutions
Table 11. Roche Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Oxford Immunotec Corporate Information, Location and Competitors
Table 13. Oxford Immunotec Tuberculosis Testing and Diagnostics Major Business
Table 14. Oxford Immunotec Tuberculosis Testing and Diagnostics Total Revenue (USD Million) (2018-2019)
Table 15. Oxford Immunotec SWOT Analysis
Table 16. Oxford Immunotec Tuberculosis Testing and Diagnostics Product and Solutions
Table 17. Oxford Immunotec Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Abbott Corporate Information, Location and Competitors
Table 19. Abbott Tuberculosis Testing and Diagnostics Major Business
Table 20. Abbott Tuberculosis Testing and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 21. Abbott SWOT Analysis
Table 22. Abbott Tuberculosis Testing and Diagnostics Product and Solutions
Table 23. Abbott Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Thermo Fischer Scientific Corporate Information, Location and Competitors
Table 25. Thermo Fischer Scientific Tuberculosis Testing and Diagnostics Major Business
Table 26. Thermo Fischer Scientific Tuberculosis Testing and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 27. Thermo Fischer Scientific SWOT Analysis
Table 28. Thermo Fischer Scientific Tuberculosis Testing and Diagnostics Product and Solutions
Table 29. Thermo Fischer Scientific Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Sanofi Corporate Information, Location and Competitors
Table 31. Sanofi Tuberculosis Testing and Diagnostics Major Business
Table 32. Sanofi Tuberculosis Testing and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 33. Sanofi SWOT Analysis
Table 34. Sanofi Tuberculosis Testing and Diagnostics Product and Solutions
Table 35. Sanofi Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Becton Dickinson Corporate Information, Location and Competitors
Table 37. Becton Dickinson Tuberculosis Testing and Diagnostics Major Business
Table 38. Becton Dickinson Tuberculosis Testing and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 39. Becton Dickinson SWOT Analysis
Table 40. Becton Dickinson Tuberculosis Testing and Diagnostics Product and Solutions
Table 41. Becton Dickinson Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Par Sterile Corporate Information, Location and Competitors
Table 43. Par Sterile Tuberculosis Testing and Diagnostics Major Business
Table 44. Par Sterile Tuberculosis Testing and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 45. Par Sterile SWOT Analysis
Table 46. Par Sterile Tuberculosis Testing and Diagnostics Product and Solutions
Table 47. Par Sterile Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Qiagen Corporate Information, Location and Competitors
Table 49. Qiagen Tuberculosis Testing and Diagnostics Major Business
Table 50. Qiagen Tuberculosis Testing and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 51. Qiagen SWOT Analysis
Table 52. Qiagen Tuberculosis Testing and Diagnostics Product and Solutions
Table 53. Qiagen Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Hologic Corporate Information, Location and Competitors
Table 55. Hologic Tuberculosis Testing and Diagnostics Major Business
Table 56. Hologic Tuberculosis Testing and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 57. Hologic SWOT Analysis
Table 58. Hologic Tuberculosis Testing and Diagnostics Product and Solutions
Table 59. Hologic Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. BioMerieux Corporate Information, Location and Competitors
Table 61. BioMerieux Tuberculosis Testing and Diagnostics Major Business
Table 62. BioMerieux Tuberculosis Testing and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 63. BioMerieux SWOT Analysis
Table 64. BioMerieux Tuberculosis Testing and Diagnostics Product and Solutions
Table 65. BioMerieux Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Hain Lifescience Corporate Information, Location and Competitors
Table 67. Hain Lifescience Tuberculosis Testing and Diagnostics Major Business
Table 68. Hain Lifescience Tuberculosis Testing and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 69. Hain Lifescience SWOT Analysis
Table 70. Hain Lifescience Tuberculosis Testing and Diagnostics Product and Solutions
Table 71. Hain Lifescience Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Bio-Rad Laboratories Corporate Information, Location and Competitors
Table 73. Bio-Rad Laboratories Tuberculosis Testing and Diagnostics Major Business
Table 74. Bio-Rad Laboratories Tuberculosis Testing and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 75. Bio-Rad Laboratories SWOT Analysis
Table 76. Bio-Rad Laboratories Tuberculosis Testing and Diagnostics Product and Solutions
Table 77. Bio-Rad Laboratories Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Epistem Corporate Information, Location and Competitors
Table 79. Epistem Tuberculosis Testing and Diagnostics Major Business
Table 80. Epistem Tuberculosis Testing and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 81. Epistem SWOT Analysis
Table 82. Epistem Tuberculosis Testing and Diagnostics Product and Solutions
Table 83. Epistem Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Siemens Healthineer Corporate Information, Location and Competitors
Table 85. Siemens Healthineer Tuberculosis Testing and Diagnostics Major Business
Table 86. Siemens Healthineer Tuberculosis Testing and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 87. Siemens Healthineer SWOT Analysis
Table 88. Siemens Healthineer Tuberculosis Testing and Diagnostics Product and Solutions
Table 89. Siemens Healthineer Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Akonni Biosystems Corporate Information, Location and Competitors
Table 91. Akonni Biosystems Tuberculosis Testing and Diagnostics Major Business
Table 92. Akonni Biosystems Tuberculosis Testing and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 93. Akonni Biosystems SWOT Analysis
Table 94. Akonni Biosystems Tuberculosis Testing and Diagnostics Product and Solutions
Table 95. Akonni Biosystems Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Creative Diagnostics Corporate Information, Location and Competitors
Table 97. Creative Diagnostics Tuberculosis Testing and Diagnostics Major Business
Table 98. Creative Diagnostics Tuberculosis Testing and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 99. Creative Diagnostics SWOT Analysis
Table 100. Creative Diagnostics Tuberculosis Testing and Diagnostics Product and Solutions
Table 101. Creative Diagnostics Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Cepheid Corporate Information, Location and Competitors
Table 103. Cepheid Tuberculosis Testing and Diagnostics Major Business
Table 104. Cepheid Tuberculosis Testing and Diagnostics Total Revenue (USD Million) (2017-2018)
Table 105. Cepheid SWOT Analysis
Table 106. Cepheid Tuberculosis Testing and Diagnostics Product and Solutions
Table 107. Cepheid Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Global Tuberculosis Testing and Diagnostics Revenue (Million USD) by Players (2015-2020)
Table 109. Global Tuberculosis Testing and Diagnostics Revenue Share by Players (2015-2020)
Table 110. Global Tuberculosis Testing and Diagnostics Revenue (Million USD) by Regions (2015-2020)
Table 111. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Regions (2015-2020)
Table 112. North America Tuberculosis Testing and Diagnostics Revenue by Countries (2015-2020)
Table 113. North America Tuberculosis Testing and Diagnostics Revenue Market Share by Countries (2015-2020)
Table 114. Europe Tuberculosis Testing and Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 115. Asia-Pacific Tuberculosis Testing and Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 116. South America Tuberculosis Testing and Diagnostics Revenue by Countries (2015-2020)
Table 117. South America Tuberculosis Testing and Diagnostics Revenue Market Share by Countries (2015-2020)
Table 118. Middle East and Africa Tuberculosis Testing and Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 119. Middle East and Africa Tuberculosis Testing and Diagnostics Revenue Market Share by Countries (2015-2020)
Table 120. Global Tuberculosis Testing and Diagnostics Revenue (Million USD) by Type (2015-2020)
Table 121. Global Tuberculosis Testing and Diagnostics Revenue Share by Type (2015-2020)
Table 122. Global Tuberculosis Testing and Diagnostics Revenue Forecast by Type (2021-2025)
Table 123. Global Tuberculosis Testing and Diagnostics Revenue by Application (2015-2020)
Table 124. Global Tuberculosis Testing and Diagnostics Revenue Share by Application (2015-2020)
Table 125. Global Tuberculosis Testing and Diagnostics Revenue Forecast by Application (2021-2025)
Table 126. Global Tuberculosis Testing and Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Tuberculosis Testing and Diagnostics Picture
Figure 2. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Type in 2019
Figure 3. Smear Microscopy Picture
Figure 4. Nucleic Acid Testing Picture
Figure 5. Radiography Picture
Figure 6. Tuberculin Skin Test (TST) Picture
Figure 7. Interferon Gamma Released Assay (IGRA) Picture
Figure 8. Others Picture
Figure 9. Tuberculosis Testing and Diagnostics Revenue Market Share by Application in 2019
Figure 10. Hospitals and Clinics Picture
Figure 11. Diagnostic Laboratories Picture
Figure 12. Others Picture
Figure 13. Global Tuberculosis Testing and Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Tuberculosis Testing and Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Tuberculosis Testing and Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Tuberculosis Testing and Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Tuberculosis Testing and Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Tuberculosis Testing and Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Tuberculosis Testing and Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Tuberculosis Testing and Diagnostics Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Tuberculosis Testing and Diagnostics Revenue Market Share in 2019
Figure 22. Global Top 10 Players Tuberculosis Testing and Diagnostics Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Tuberculosis Testing and Diagnostics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Regions (2015-2020)
Figure 26. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Regions in 2018
Figure 27. North America Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 28. Europe Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 30. South America Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 32. North America Tuberculosis Testing and Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 33. North America Tuberculosis Testing and Diagnostics Revenue Market Share by Countries in 2019
Figure 34. USA Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 35. Canada Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 37. Europe Tuberculosis Testing and Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Tuberculosis Testing and Diagnostics Revenue Market Share by Countries in 2019
Figure 39. Germany Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 40. UK Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 41. France Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 42. Russia Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 43. Italy Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Tuberculosis Testing and Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Tuberculosis Testing and Diagnostics Revenue Market Share by Countries in 2019
Figure 46. China Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 47. Japan Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 48. Korea Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 49. India Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 51. South America Tuberculosis Testing and Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 52. South America Tuberculosis Testing and Diagnostics Revenue Market Share by Countries in 2019
Figure 53. Brazil Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Tuberculosis Testing and Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Tuberculosis Testing and Diagnostics Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 58. UAE Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2015-2020)
Figure 61. Global Tuberculosis Testing and Diagnostics Revenue Share by Type (2015-2020)
Figure 62. Global Tuberculosis Testing and Diagnostics Revenue Share by Type in 2019
Figure 63. Global Tuberculosis Testing and Diagnostics Market Share Forecast by Type (2021-2025)
Figure 64. Global Smear Microscopy Revenue Growth Rate (2015-2020)
Figure 65. Global Nucleic Acid Testing Revenue Growth Rate (2015-2020)
Figure 66. Global Radiography Revenue Growth Rate (2015-2020)
Figure 67. Global Tuberculin Skin Test (TST) Revenue Growth Rate (2015-2020)
Figure 68. Global Interferon Gamma Released Assay (IGRA) Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Tuberculosis Testing and Diagnostics Revenue Share by Application (2015-2020)
Figure 71. Global Tuberculosis Testing and Diagnostics Revenue Share by Application in 2019
Figure 72. Global Tuberculosis Testing and Diagnostics Market Share Forecast by Application (2021-2025)
Figure 73. Global Hospitals and Clinics Revenue Growth Rate (2015-2020)
Figure 74. Global Diagnostic Laboratories Revenue Growth Rate (2015-2020)
Figure 75. Global Others Revenue Growth Rate (2015-2020)
Figure 76. Global Tuberculosis Testing and Diagnostics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Tuberculosis Testing and Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Tuberculosis Testing and Diagnostics Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Tuberculosis Testing and Diagnostics Revenue Market Forecast (2021-2025)
Figure 80. Europe Tuberculosis Testing and Diagnostics Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Tuberculosis Testing and Diagnostics Revenue Market Forecast (2021-2025)
Figure 82. South America Tuberculosis Testing and Diagnostics Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Tuberculosis Testing and Diagnostics Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
結核感染検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Tuberculosis Infection Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…- 結核診断・治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Tuberculosis Diagnosis and Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tubercul…
- 感染症検査における分子診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Molecular Diagnostics in Infectious Disease Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 201…
- 膣炎迅速検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Vaginosis Rapid Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Vaginosis Rapid Testi…
- 肺炎球菌検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Pneumococcal Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …